171 related articles for article (PubMed ID: 10912964)
21. The management of hemolytic disease in the fetus and newborn.
Bowman J
Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
[TBL] [Abstract][Full Text] [Related]
22. Anti-M isoimmunization: management and outcome at the Ohio State University from 1969 to 1995.
De Young-Owens A; Kennedy M; Rose RL; Boyle J; O'Shaughnessy R
Obstet Gynecol; 1997 Dec; 90(6):962-6. PubMed ID: 9397112
[TBL] [Abstract][Full Text] [Related]
23. Management of Kell isoimmunization--evaluation of a Doppler-guided approach.
Rimon E; Peltz R; Gamzu R; Yagel S; Feldman B; Chayen B; Achiron R; Lipitz S
Ultrasound Obstet Gynecol; 2006 Nov; 28(6):814-20. PubMed ID: 16941575
[TBL] [Abstract][Full Text] [Related]
24. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
25. Non-rhesus (D) blood group isoimmunization in obstetrics.
Beal RW
Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
[No Abstract] [Full Text] [Related]
26. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
Vaughan JI; Manning M; Warwick RM; Letsky EA; Murray NA; Roberts IA
N Engl J Med; 1998 Mar; 338(12):798-803. PubMed ID: 9504940
[TBL] [Abstract][Full Text] [Related]
27. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
Wenk RE; Goldstein P; Felix JK
Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
[TBL] [Abstract][Full Text] [Related]
28. Non-anti-D antibodies in red-cell alloimmunization.
Moise KJ
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
[TBL] [Abstract][Full Text] [Related]
29. Red cell antigens. The fetus as a patient.
Huntley B
Lancet; 2001 Dec; 358 Suppl():S58. PubMed ID: 11784607
[No Abstract] [Full Text] [Related]
30. [Irregular blood group antibodies during pregnancy: screening is mandatory].
Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
[TBL] [Abstract][Full Text] [Related]
31. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
Zlatnik FJ
Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
[No Abstract] [Full Text] [Related]
32. Diagnostic fetal umbilical blood sampling in the management of isoimmunization.
Reece EA; Copel JA; Scioscia AL; Grannum PA; DeGennaro N; Hobbins JC
Am J Obstet Gynecol; 1988 Nov; 159(5):1057-62. PubMed ID: 3142263
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses.
Mari G; Deter RL; Carpenter RL; Rahman F; Zimmerman R; Moise KJ; Dorman KF; Ludomirsky A; Gonzalez R; Gomez R; Oz U; Detti L; Copel JA; Bahado-Singh R; Berry S; Martinez-Poyer J; Blackwell SC
N Engl J Med; 2000 Jan; 342(1):9-14. PubMed ID: 10620643
[TBL] [Abstract][Full Text] [Related]
34. [Follow-up of pregnancies with red-cell allo-immunisation: State-of-the art].
Carbonne B; Castaigne V; Cynober E; Levy R; Cortey A; Mailloux A; Larsen M; Brossard Y
Gynecol Obstet Fertil; 2010 Mar; 38(3):205-13. PubMed ID: 20207183
[TBL] [Abstract][Full Text] [Related]
35. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
[TBL] [Abstract][Full Text] [Related]
36. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
37. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
Gottvall T; Hildén JO
Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
[TBL] [Abstract][Full Text] [Related]
38. [A clinical case of pregnancy isoimmunization caused by the Kell system].
Orsini G; Serratì A; Schonauer S; Cramarossa D
Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610
[No Abstract] [Full Text] [Related]
39. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
40. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
Lenkiewicz B; Zupańska B
Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
